Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MYC | P01106 | 1/20 | 0.63 |
| ▸ | MAX | P61244 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | NQO2 | P16083 | 9/20 | 0.47 |
| ▸ | ACHE | P22303 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.40 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25307871 | 0.87 | MYC (0.43) | MYCMAXMAPTALDH1A1KMT2A | |
| SCHEMBL29939187 | 0.87 | MYC (0.43) | MYCMAXMAPTALDH1A1KMT2A | |
| SCHEMBL3721359 | 0.78 | MYC (0.53) | MYCMAXMAPTALDH1A1KMT2A | |
| SCHEMBL29737179 | 0.78 | MYC (1.00) | MYCMAXMAPTALDH1A1KMT2A | |
| SCHEMBL14328958 | 0.78 | MYC (1.00) | MYCMAXMAPTALDH1A1KMT2A | |
| SCHEMBL29489945 | 0.77 | NQO2 (0.62) | MYCMAXMAPTALDH1A1KMT2A | |
| SCHEMBL2367850 | 0.77 | NQO2 (0.62) | MYCMAXMAPTALDH1A1KMT2A | |
| SCHEMBL6881938 | 0.77 | MAPT (0.63) | MYCMAXMAPTALDH1A1KMT2A | |
| SCHEMBL29966114 | 0.77 | MAPT (0.63) | MYCMAXMAPTALDH1A1KMT2A | |
| SCHEMBL31070283 | 0.77 | MAPT (0.63) | MYCMAXMAPTALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230411662-A1 | Electrolyte Regeneration for Organic Redox Flow Batteries Based on Water-Soluble Phenzaine-Based Compounds | CMBLU ENERGY AG (DE) | 2023-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230411662-A1 | Electrolyte Regeneration for Organic Redox Flow Batteries Based on Water-Soluble Phenzaine-Based Compounds | SLC6A12, POF1B, GPX4 | MYC 1379/4885MAX 1514/4885MAPT 2869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.